Interviews

Dr Wahood discusses trends reshaping the landscape of mechanical thrombectomy for acute ischemic stroke, particularly in patients with atrial fibrillation.

Dr Madassery explores why calcified lesions continue to complicate treatment.

Dr Dania Daye discusses the need for standardized reporting in AI studies and reflects on key themes from her recent keynote at the Society of Interventional Oncology (SIO) conference.

Dr. Srini Tummala outlines the essential components of a high-quality noninvasive vascular assessment for patients with chronic limb-threatening ischemia.

Despite advances, women with AAA continue to experience disproportionately higher mortality rates and remain significantly underrepresented in clinical trials.

Dr Maldonado discusses the design and significance of the STRIDE trial, highlights key findings, and explains how these data may inform endovascular treatment strategies.

Dr Salazar emphasizes the importance of maintaining a comprehensive, systems-based approach to venous assessment.

Dr Mitchell D. Weinberg discusses the advantages of the FlowTriever system (Inari Medical) and how mechanical thrombectomy is evolving within the field of interventional cardiology.

Nicolas J. Mouawad, MD, asks if lytic-based thrombectomy is still relevant and discusses how non–lytic-based therapies provide a better safety profile and lower bleeding risk.

Kyle S. Stumetz, DO, winner of the 2025 CIO Young Investigator Award, discusses his study, “Absorbable Gelatin Hydrodissection in Oncologic Thermal Ablations: Initial Outcomes.”